Myocardial ischemic-reperfusion injury in a rat model of metabolic syndrome

Obesity

Volumn 16, Issue 10, 2008, Pages 2253-2258

  Mozaffari, Mahmood S ^a   Schaffer, Stephen W ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LEPTIN; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; FAT INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEART CONTRACTION; HEART INFARCTION; HEART VENTRICLE PRESSURE; HYPERTENSION; MALE; METABOLIC SYNDROME X; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; REPERFUSION INJURY; SALT INTAKE; TIME; WISTAR KYOTO RAT;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; DIETARY FATS; DISEASE MODELS, ANIMAL; GLUCOSE INTOLERANCE; HYPERTENSION; INSULIN; LEPTIN; MALE; METABOLIC SYNDROME X; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, INBRED WKY; SODIUM CHLORIDE, DIETARY; STREPTOZOCIN; TIME FACTORS; TRIGLYCERIDES; VENTRICULAR PRESSURE;

RATTUS;

EID: 53849142124     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.356     Document Type: Article

References (35)

1. Cooper-DeHoff RM, Pepine CJ. Metabolic syndrome and cardiovascular disease: challenges and opportunities. Clin Cardiol 2007;30:593-597.
2. Toto RD. Heart disease in diabetic patients. Semin Nephrol 2005;25:372-378.
3. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003;144:5159-5165.
4. Relling DP, Esberg LB, Johnson WT et al. Dietary interaction of high fat and marginal copper deficiency on cardiac contractile function. Obesity (Silver Spring) 2007;15:1242-1257.
5. Relling DP, Esberg LB, Fang CX et al. High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis. J Hypertens 2006;24:549-561.
6. McGavock JM, Victor RG, Unger RH, Szczepaniak LS; American College of Physicians and the American Physiological Society. Adiposity of the heart, revisited. Ann Intern Med 2006;144:517-524.
7. Ouwens DM, Diamant M, Fodor M et al. Cardiac contractile dysfunction in insulin resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia 2007;50:1938-1948.
8. Rennison JH, McElfresh TA, Okere IC et al. High-fat diet postinfarction enhances mitochondrial function and does not exacerbate left ventricular dysfunction. Am J Physiol Heart Circ Physiol 2007;292:H1498-H1506.
9. Okere IC, Chandler MP, McElfresh TA et al. Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin. Am J Physiol Heart Circ Physiol 2006;291:H38-H44.
10. Okere IC, Chess DJ, McElfresh TA et al. High-fat diet prevents cardiac hypertrophy and improves contractile function in the hypertensive Dahl salt-sensitive rat. Clin Exp Pharmacol Physiol 2005;32:825-831.
11. Schaub MC, Hefti MA, Zaugg M. Integration of calcium with the signaling network in cardiac myocytes. J Mol Cell Cardiol 2006;41:183-214.
12. Unger RH. Lipotoxic diseases. Annu Rev Med 2002;53:319-336.
13. Sparagna GC, Hickson-Bick DL, Buja LM, McMillin JB. A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 2000;279:H2124-H2132.
14. Ricci C, Pastukh V, Schaffer S. Role of oxidative mitochondrial DNA damage in fatty acid-induced apoptosis. FASEB J 2006;20:A121.
15. Rahmouni K, Correia MLG, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005;45:9-14.
16. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006;64:355-365.
17. Paulson DJ. The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res 1997;34:104-112.
18. Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res 1997;34:113-120.
19. Mozaffari MS, Schaffer SW. Effect of hypertension and hypertension-glucose intolerance on myocardial ischemic injury. Hypertension 2003;42:1042-1049.
20. Mozaffari MS, Patel C, Warren BK, Schaffer SW. NaCl-induced hypertensive rat model of non-insulin-dependent diabetes: role of sympathetic modulation. Am J Hypertens 2000;13:540-546.
21. 2+ channel. Hypertension 2006;47:912-919.
22. Mozaffari MS, Patel C, Ballas C, Schaffer SW. Effects of excess salt and fat intake on myocardial function and infarct size in rat. Life Sci 2006;78:1808-1813.
23. Schaffer SW, Mozaffari MS. The neonatal STZ model of diabetes. In: McNeil JH (ed). Experimental Models of Diabetes. CRC Press: Boca Raton, FL, 1999, pp 231-255.
24. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-671.
25. Miyashita Y, Nishimura R, Morimoto A et al. Glycated albumin is low in obese, type 2 diabetic patients. Diabetes Res Clin Pract 2007;78:51-55.
26. Schaffer SW, Croft CB, Solodushko V. Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. Am J Physiol Heart Circ Physiol 2000;278:H1948-H1954.
27. Finck BN, Han X, Courtois M et al. A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 2003;100:1226-1231.
28. Golfman LS, Wilson CR, Sharma S et al. Activation of PPARγ enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. Am J Physiol Endocrinol Metab 2005;289:E328-E336.
29. Buchanan J, Mazumder PK, Hu P et al. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 2005;146:5341-5349.
30. Lopaschuk GD, Spafford M. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circ Res 1989;65:378-387.
31. Yue TL, Nerurkar SS, Bao W et al. In vivo activation of peroxisome proliferator-activated receptor-? protects the heart from ischemia/reperfusion injury in Zucker fatty rats. J Pharmacol Exp Ther 2008;325:466-474.
32. Smith CC, Mocanu MM, Davidson SM et al. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol 2006;149:5-13.
33. Sambandam N, Morabito D, Wagg C et al. Chronic activation of PPARα is detrimental to cardiac recovery after ischemia. Am J Physiol Heart Circ Physiol 2006;290:H87-H95.
34. Thibault H, Piot C, Staat P et al. Long-term benefit of postconditioning. Circulation 2008;117:1037-1044.
35. ATP channels and GSK-3β: interaction with the MPT pore. Am J Hypertens 2008;21:570-575.